Primary |
Bone Pain |
20.0% |
Hypertension |
13.3% |
Anaemia |
6.7% |
Constipation |
6.7% |
Gastric Ulcer |
6.7% |
Hyperlipidaemia |
6.7% |
Musculoskeletal Chest Pain |
6.7% |
Prophylaxis |
6.7% |
Prostate Cancer |
6.7% |
Sedation |
6.7% |
Spinal Pain |
6.7% |
Thrombosis Prophylaxis |
6.7% |
|
Nausea |
50.0% |
Post Procedural Haemorrhage |
50.0% |
|
Secondary |
Drug Use For Unknown Indication |
39.6% |
Acute Myocardial Infarction |
9.7% |
Product Used For Unknown Indication |
7.7% |
Thrombosis Prophylaxis |
6.8% |
Hypertension |
3.9% |
Hypertonia |
3.9% |
Angina Pectoris |
3.4% |
Atrial Fibrillation |
3.4% |
Type Ii Diabetes Mellitus |
2.9% |
Arthralgia |
2.4% |
Coronary Artery Disease |
2.4% |
Depression |
1.9% |
Prophylaxis |
1.9% |
Arthritis |
1.4% |
Asthma |
1.4% |
Cardiac Disorder |
1.4% |
Cardiovascular Event Prophylaxis |
1.4% |
Diabetes Mellitus |
1.4% |
Multiple Myeloma |
1.4% |
Myocardial Infarction |
1.4% |
|
Cerebral Haemorrhage |
8.3% |
Gastrointestinal Haemorrhage |
8.3% |
Vitreous Haemorrhage |
8.3% |
Epistaxis |
6.3% |
Gastric Ulcer |
6.3% |
Melaena |
6.3% |
Thrombocytopenia |
6.3% |
Vitamin B12 Abnormal |
6.3% |
Diverticulitis |
4.2% |
Haematemesis |
4.2% |
Haematoma |
4.2% |
Hemiparesis |
4.2% |
Intra-abdominal Haemorrhage |
4.2% |
Postmenopausal Haemorrhage |
4.2% |
Sudden Cardiac Death |
4.2% |
Tricuspid Valve Incompetence |
4.2% |
Vomiting |
4.2% |
Arthralgia |
2.1% |
Circulatory Collapse |
2.1% |
Dizziness |
2.1% |
|
Concomitant |
Drug Use For Unknown Indication |
22.6% |
Product Used For Unknown Indication |
20.8% |
Hypertension |
12.7% |
Diabetes Mellitus |
5.6% |
Rheumatoid Arthritis |
4.6% |
Prostate Cancer |
4.4% |
Essential Hypertension |
4.0% |
Pain |
3.3% |
Prophylaxis |
2.4% |
Hyperlipidaemia |
2.2% |
Cardiac Failure |
2.1% |
Thrombosis Prophylaxis |
2.0% |
Atrial Fibrillation |
2.0% |
Renal Failure Chronic |
1.8% |
Type 2 Diabetes Mellitus |
1.7% |
Myocardial Infarction |
1.7% |
Angina Pectoris |
1.6% |
Hypercholesterolaemia |
1.5% |
Non-small Cell Lung Cancer |
1.5% |
Acute Coronary Syndrome |
1.5% |
|
Vomiting |
14.8% |
Renal Failure Acute |
7.6% |
Hypotension |
7.1% |
Pyrexia |
6.2% |
Syncope |
6.2% |
Weight Decreased |
6.2% |
Myocardial Infarction |
5.2% |
Orthostatic Hypotension |
5.2% |
Transaminases Increased |
5.2% |
Cerebrovascular Accident |
4.8% |
Cerebral Infarction |
3.8% |
Pain In Extremity |
3.3% |
Palpitations |
3.3% |
Staphylococcal Sepsis |
3.3% |
Thrombosis |
3.3% |
Nausea |
2.9% |
Pneumonia |
2.9% |
Pulmonary Embolism |
2.9% |
Pulmonary Oedema |
2.9% |
Sepsis |
2.9% |
|
Interacting |
Depression |
16.7% |
Knee Arthroplasty |
16.7% |
Product Used For Unknown Indication |
16.7% |
Thrombosis Prophylaxis |
16.7% |
Hypothyroidism |
8.3% |
Knee Operation |
8.3% |
Pain Management |
8.3% |
Procedural Pain |
8.3% |
|
Procedural Nausea |
25.0% |
Rectal Ulcer |
25.0% |
Tremor |
25.0% |
Upper Gastrointestinal Haemorrhage |
25.0% |
|